Correlation Engine 2.0
Clear Search sequence regions


  • apoptosis (1)
  • CD44 (1)
  • cytokines (6)
  • Gal- 8 (10)
  • galectins (2)
  • humans (1)
  • IL 1β (1)
  • IL 6 (1)
  • integrins (1)
  • JNK (1)
  • KO (2)
  • lectins (2)
  • LGALS8 protein (1)
  • LRP1 (1)
  • MCP 1 (1)
  • mice (1)
  • MRC2 (1)
  • NF κB (1)
  • patients (1)
  • poor prognosis (1)
  • protein human (1)
  • RANKL (1)
  • receptor complexes (1)
  • receptors (1)
  • SDF 1 (1)
  • signal (1)
  • tumor size (1)
  • uPAR (1)
  • Sizes of these terms reflect their relevance to your search.

    Galectin-8 (Gal-8) belongs to a family of animal lectins that modulate cell adhesion, cell proliferation, apoptosis, and immune responses. Recent studies have shown that mammalian Gal-8 induces in an autocrine and paracrine manner, the expression and secretion of cytokines and chemokines such as RANKL, IL-6, IL-1β, SDF-1, and MCP-1. This involves Gal-8 binding to receptor complexes that include MRC2/uPAR/LRP1, integrins, and CD44. Receptors ligation triggers FAK, ERK, Akt, and the JNK signaling pathways, leading to induction of NF-κB that promotes cytokine expression. Indeed, immune-competent Gal-8 knockout (KO) mice express systemic lower levels of cytokines and chemokines while the opposite is true for Gal-8 transgenic animals. Cytokine and chemokine secretion, induced by Gal-8, promotes the migration of cancer cells toward cells expressing this lectin. Accordingly, Gal-8 KO mice experience reduced tumor size and smaller and fewer metastatic lesions when injected with cancer cells. These observations suggest the existence of a 'vicious cycle' whereby Gal-8 expression and secretion promotes the secretion of cytokines and chemokines that further promote Gal-8 expression. This 'vicious cycle' could enhance the development of a 'cytokine storm' which is a key contributor to the poor prognosis of COVID-19 patients. © 2022 The Author(s).

    Citation

    Yehiel Zick. Galectin-8, cytokines, and the storm. Biochemical Society transactions. 2022 Feb 28;50(1):135-149

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35015084

    View Full Text